Expert Interview
A third look: Discussing the full data for Petosemtamab from Merus and the abstract for Ficerafusp alfa for Bicara presented at ASCO
Ticker(s): MRUS, BCAXInstitution: UCLA
- Associate Clinical Professor, Department of Medicine, Division of Hematology-Oncology at UCLA
- Leads the translational and clinical research in head and neck cancers for the UCLA Division of Hematology-Oncology.
- Focus of her research is in identification of novel therapeutics for head and neck squamous cell carcinoma (HNSCC) and in understanding mechanisms of resistance to existing therapies.
How promising is the data for petosemtamab?
Added By: wilson_adminHow promising is the abstract for Ficerafusp alfa
Added By: wilson_adminHow do you envision these investigational agents being used in HSNCC
Added By: wilson_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
